Detects sequence variants in the GJB2 gene and deletions in the GJB6 gene in patients with sensorineural non-syndromic hearing loss. Mutations in the gap junction protein beta-2 gene ('GJB2') are known to be responsible for mild to profound congenital and late-onset hearing loss. This study aimed to investigate the molecular basis of progressive hearing loss compared with non-progressive hearing loss.
No special preparation is needed for Connexin 30. Inform your doctor if you are on any medications or have any underlying medical conditions or allergies before undergoing Connexin 30. Your doctor depending on your condition will give specific instructions.
|All age groups
|Mutations of both the copies of gene are seen in positive cases